Subscribe
shutterstock-54582826-web
Pincasso / Shutterstock.com
18 December 2014Big Pharma

French pharma company moves its IP to Ireland

France-based pharmaceutical company Flamel Technologies has moved its IP to Ireland.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Pressure on Ireland to back COVID vaccine IP waiver
12 March 2021   Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.


Editor's picks

Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

Editor's picks

Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024

More on this story

Big Pharma
Pressure on Ireland to back COVID vaccine IP waiver
12 March 2021   Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.

More on this story

Big Pharma
Pressure on Ireland to back COVID vaccine IP waiver
12 March 2021   Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.

More features

HLK adds CRISPR specialist as partner
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
UPC delivers first 'imminent infringement' decision in biosimilar dispute
AstraZeneca unit draws line under Samsung dispute
Brown Rudnick expands with new partner duo
UPC: First decisions on merits are ‘testimony to judges’ tight case management’
Morgan Lewis adds two partners to London office
UK firm prevails in ‘exceptionally slow’ UPC test case